The protective role of albumin in clostridium difficile infection: A step toward solving the puzzle

Infection Control and Hospital Epidemiology

Volumn 36, Issue 12, 2015, Pages 1478-1479

  Di Bella, Stefano ^a   Di Masi, Alessandra ^b   Turla, Simona ^b   Ascenzi, Paolo ^b   Gouliouris, Theodore ^c   Petrosillo, Nicola ^d  

^a SAN GERARDO HOSPITAL   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOTOXIN; ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HUMAN SERUM ALBUMIN; NITRIC OXIDE; SUPEROXIDE; ANTIINFECTIVE AGENT;

ALBUMIN BLOOD LEVEL; ARTICLE; CACO 2 CELL LINE; CLOSTRIDIUM DIFFICILE INFECTION; COLORECTAL CARCINOMA; CYTOTOXICITY; ENDOTHELIAL DYSFUNCTION; ENDOTOXEMIA; EXPERIMENTAL SEPTIC SHOCK; HEART MUSCLE INJURY; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; HYPOALBUMINEMIA; INFECTION PREVENTION; INTESTINE CELL; NONHUMAN; RISK FACTOR; FEMALE; INFECTION CONTROL; ISOLATION AND PURIFICATION; MALE; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; PSEUDOMEMBRANOUS COLITIS;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INFECTION CONTROL; MALE;

EID: 84958530277     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.221     Document Type: Article

References (10)

1. Tabak YP, Johannes RS, Sun X, Nunez CM, McDonald LC. Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score. Infect Control Hosp Epidemiol 2015;36:695–701.
2. Walk ST, Micic D, Jain R, et al. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 2012;55:1661–1668.
3. Kumarappa VS, Patel H, Shah A, Baddoura W, DeBari VA. Temporal changes in serum albumin and total protein in patients with hospital-acquired Clostridium difficile infection. Ann Clin Lab Sci 2014;44:32–37.
4. Anthony DM, Reynolds T, Paton J, Rafter L. Serum albumin in risk assessment for Clostridium difficile. J Hosp Infect 2009;71:378–379.
5. Henrich TJ, Krakower D, Bitton A, Yokoe DS. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis 2009;15:415–422.
6. Dansinger ML, Johnson S, Jansen PC, Opstad NL, Bettin KM, GerdingDN. Protein-losing enteropathy is associatedwith Clostridium difficile diarrhea but not with asymptomatic colonization: a prospective, case-control study. Clin Infect Dis 1996;22:932–937.
7. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Mol Aspects Med 2012;33:209–290.
8. Carter GP, Rood JI, Lyras D. The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol 2012;20:21–29.
9. Tokunaga C, Bateman RM, Boyd J, Wang Y, Russell JA, Walley KR. Albumin resuscitation improves ventricular contractility and myocardial tissue oxygenation in rat endotoxemia. Crit Care Med 2007;35:1341–1347.
10. Meziani F, Kremer H, Tesse A, et al. Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses. Am J Pathol 2007;171:1753–1761.